Portfolio News

Esperion Therapeutics Completes $22.75M Series A
Esperion Therapeutics, Inc., a biopharmaceutical company focused on the discovery and development of compounds to treat cardiovascular and metabolic disease, announced it has been launched as a privately held, independent enterprise. The financing was co-led by Aisling Capital, Alta Partners and Domain Associates and also included participation by Arboretum Ventures.

Accord Biomaterials Closes $1M Series A
Accord Biomaterials, a developer of nitric oxide medical device coatings, announced the closing of a $1M Series A financing led by Arboretum Ventures.  Sigvion Capital and the University of Michigan's Wolverine Venture Fund joined Arboretum to fund Accord whose core technology was developed at the University of Michigan and MC3 Corporation.

Online Health Counseling Grows HealthMedia
HealthMedia, a global leader in online delivery of behavior change interventions, saw health care license revenue growth jump 100 percent in the third quarter of 2007. HealthMedia's technology helps patients with everything from wellness regimens to taking their medication.

CardioMEMS Closes Series E Financing and Appoints New CFO
CardioMEMS Inc., a developer of wireless pressure sensors for the management of cardiovascular disease, announced the closing of its $33 million Series E Preferred Stock financing.  The Board of Directors of CardioMEMS also announced that it has appointed Daniel H. Bauer as Chief Financial Officer of the Company.

CardioMEMS Announces Start of CHAMPION Pivotal Study
CardioMEMS Inc., a developer of wireless pressure sensors for the management of cardiovascular disease, announced that its wireless pressure sensor for heart failure (HF) monitoring was successfully implanted in two patients at Saint Thomas Hospital in Nashville, Tennessee.  These patient implants mark the initiation of the CHAMPION pivotal clinical study.

Mirabilis Medica Closes Series A Extension
Mirabilis Medica, a privately-held medical device company announced the closing of a $10.5 million extension to its series A financing which was originally led by Charter Life Sciences and vSpring Capital last year. The series A extension was led by Arboretum Ventures, and included Split Rock Partners, Dow Venture Capital and an individual investor.

KFx Medical Corporation Closes Series B Financing
KFx Medical Corporation, a developer of minimally invasive percutaneous repair systems for rotator cuff repair, has closed a Series B financing. Investors in the $10M Series B round include lead investor Alloy Ventures, and returning investors Charter Life Sciences L.P., Arboretum Ventures, Montreux Equity Partners, and MB Venture Partners.

Accuri Cytometers Adds Two Executives to its Board of Directors
Accuri Cytometers, Inc., a life science company developing bench-top flow cytometer systems, announced the appointment of Daniel J. Calvo and George W. Dunbar to its Board of Directors. Daniel Calvo is currently President and CEO of Assay Designs, and George Dunbar is currently President, CEO and a Director of Aastrom Biosciences.

HealthMedia will Offer Online Programs for Free
HealthMedia Inc., a global leader in online delivery of behavior change interventions, will offer seven of its programs for free to Washtenaw County, Michigan residents for the next 12 months. Residents will be able to access HealthMedia's web-based programs that help people manage health behavior in areas such as smoking, weight loss or diabetes management.

Accuri Cytometers Announces Completion of Series B Financing
Accuri Cytometers Inc., a medical equipment company developing bench-top flow cytometer systems, announced the completion of a $5 million Series B financing led by Baird Venture Partners (BVP). Arboretum Ventures co-led the financing, with both firms being new investors in Accuri.

CardioMEMS Announces FDA Clearance
CardioMEMS Inc., a developer of wireless pressure sensors for the management of cardiovascular disease, announced March 28, 2007 Food and Drug Administration (FDA) clearance of the EndoSure AAA Wireless Pressure Measurement System for measuring intrasac pressure during thoracic aortic aneurysm repair.

HealthMedia’s Health Risk Assessment Now Available
HealthMedia, Inc., the global leader in scalable behavior change interventions, announced that the nation’s leading integrated health plan Kaiser Permanente, has selected HealthMedia Succeed as its program-wide Health Risk Assessment (HRA) solution across all national regions.

Asterand Offers Researchers Internet Access to RNA
Asterand, a leading provider of human tissue and related services, announced that it is offering research scientists access to human RNA samples via the internet to speed drug discovery. RNA analysis is an effective way of differentiating between the diseased state and normal state of tissues.

Inogen Secures $22 Million in Financing
Inogen, a leading developer of long-term oxygen therapy technologies, announced February 15, 2007 that it has secured $22 million in funding from first time investors Arboretum Ventures and Novo A/S, who joined existing investors Versant Ventures, Accuitive Medical Partners and Avalon Investments.

CardioMEMS Announces First Patient Implant of Wireless Pressure Sensor
CardioMEMS Inc., a developer of wireless pressure sensors for the management of cardiovascular disease, announced that its wireless pressure sensor for heart failure monitoring was successfully implanted in two patients at Okalahoma Heart Hospital under the direction of Philip Adamson, MD, Director of the Heart Failure Institute.

HealthMedia Acquires MySelfHelp.com
HealthMedia, a global leader in online delivery of behavior change interventions, announced that it has acquired MySelfHelp.com. MySelfHelp.com offers behavioral health programs for treating depression and insomnia. The acquisition will enhance the product line of HealthMedia, allowing it to provide a more comprehensive set of programs to its customers.

NeoGuide Systems Closes Series C Financing
NeoGuide Systems announced that it raised $25 million in its Series C Round. NeoGuide has developed a computer-assisted colonoscopy system designed to enhance physician control, making the procedure faster and less painful for the patient. The company received FDA clearance for the device earlier this year and expects to begin commercialization in 2007.

NeoGuide Names New President and Chief Executive Officer
NeoGuide Systems Inc., a developer of technology to prevent and treat colorectal cancer, named Austin Noll its new President and Chief Executive Officer. Noll has nearly twenty years of experience in the medical device industry, most recently as Senior Vice President of Marketing and Business Development for Medtronic Neurologic Technologies.

CardioMEMS Closes Series D Financing, Appoints New CFO
CardioMEMS Inc., a developer of wireless pressure sensors for the management of cardiovascular disease, announced that it raised $22.6 million in equity funding. The Board of Directors also announced that it has appointed Harold W. Ingalls as Chief Financial Officer.

CardioMEMS Wins Frost and Sullivan Award 2006
CardioMEMS Inc announced that it is the recipient of the Frost and Sullivan 2006 Product Innovation of the Year Award. The Award is presented each year to the company that has demonstrated excellence in new products and technologies within its industry. CardioMEMS was recognized for its revolutionary EndoSure Wireless AAA Pressure Measurement System.

KFx Medical Receives 510K Clearance for Rotator Cuff Repair System
KFx Medical, an orthopedic medical device company, announced that it has received FDA Clearance to market its SutureCross™ Knotless Anatomic Fixation System, a minimally invasive percutaneous repair system for rotator cuff tears. The device simplifies the procedure and provides a more anatomical repair than existing techniques.

Asterand Announces Collaberation with Rubicon Genomics
Asterand, a human tissue research company, announced that it has partnered with Rubicon Genomics to discover more sensitive biomarkers for cancer diagnosis. Asterand will supply tissue and biofluid samples, and Rubicon will perform studies with the samples using its proprietary MethylPlex technology™.

HealthMedia Wins 2006 FastTrack Award
HealthMedia, a health care services company that delivers web based tailored behavior support programs, announced that it received the 2006 FastTrack Award. The Washtenaw Development Council presented the award to companies in Washtenaw County that achieved at least 20% average annual growth in the previous three years.

HandyLab Raises $5.6 Million in Equity Financing
HandyLab, Inc., a developer of clinical diagnostic tests, announced the completion of a $5.6 million round of financing, led by Pfizer Strategic Investments, a unit of Pfizer, Inc. The funds will be used to launch its first product, a rapid test for Group B strep.

Uptake Medical Closes Series A Round
Uptake Medical Corp., a medical device company, announced that it raised $9 milion in its Series A Round. The company is developing treatments for emphysema and chronic obstructive pulmonary disease (COPD).

NeoGuide Announces FDA Clearance for its Computer-Assisted Colonoscopy System
NeoGuide Systems, Inc., a developer of medical devices to prevent and treat colorectal cancer, announced that it received 510(k) clearance for its colonoscopy system. The colonoscope is designed to enhance physician control, making the procedure faster and less painful for the patient.

Shoulder Arthroscopy Market Continues to Expand
The percentage of rotator cuff procedures performed arthroscopically is forecasted to increase dramatically over the next five years as more positive clinical data continues to be published. KFx Medical plans to launch a product by the end of 2006 that it hopes will further improve clinical outcomes.

CardioMEMS Closes Series C Financing
CardioMEMS, Inc., a developer of wireless pressure sensors used in the treatment of cardiovascular disease, announced that it raised $16 million in its Series C Round. The financing was led by new investor, Medtronic, Inc. The capital will allow the company to expand the launch of its Endosure Sensor, and to begin clinical trials on its second product.

HandyLab and DuPont Announce Partnership
DuPont Qualicon and HandyLab, Inc. have announced an agreement to jointly develop new products for food testing. DuPont will use HandyLab's patented microfluidic technology to develop devices that will simplify the testing process and produce quicker results.

CardioMEMS receives FDA Clearance for its Wireless AAA Pressure Management System
CardioMEMS, Inc received FDA 510(k) approval for its EndoSure Sensor, and will begin selling the system immediately in the U.S. The sensor, which measures intrasac pressure, is implanted during endovascular abdominal aortic aneurysm (AAA) repair.

Asterand and Pharmagene to Merge
Pharmagene plc, a London based company, announced its plans to merge with Asterand Inc. The combination of the two companies will create a global leader in human tissue services. Shares of the combined entity will trade on the London Stock Exchange.

Indicates a PDF. Download the latest Acrobat Reader.

Top